Menu

Prominent Pharmacologist Dies

Bill Bowman, champion of modern anesthetics and the founding professor of pharmacology at Strathclyde University in Glasgow, has passed away at age 83.

Aug 22, 2013
Tracy Vence

BOWMAN FAMILYBill Bowman, whose work led to improvements in general anaesthetics, died July 18. He was 83. Bowman founded the U.K.’s Strathclyde University pharmacology department in 1966. He continued his research—working to understand muscle-relaxing drugs and developing safer alternatives—there in Glasgow until he was named vice principal of Strathclyde, and later retired, after 30 years with the university. Among his achievements were the development of both vecuronium and rocuronium, which today are two of the most widely used muscle relaxants in anesthetic practice. Throughout his career, Bowman was a visiting professor at several institutions across Australia, Canada, Europe, and the U.S., and served on government drug safety committees and more than a dozen editorial boards.

“We have lost an inspirational teacher, a brilliant lecturer, a walking encyclopedia of pharmacology and a mentor to numerous pharmacologists around the globe,” wrote Bowman’s colleagues Jim Parratt, Brian Furman, and Peter West in Glasgow's The Herald.

According to The Guardian, Bowman’s true calling was academic research. When he took on administrative roles at the university, he reportedly said: “Someone has to take a turn at these chores, but nothing beats contact with students and getting your hands dirty at the laboratory bench.”

Bowman is survived by two children and four grandchildren.

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!